Home Politics US baby formula crisis: Abbott could start production in 2 weeks | Economy and Business News

US baby formula crisis: Abbott could start production in 2 weeks | Economy and Business News

by YAR

Supply chain hurdles, product recalls, and runaway inflation have made it very difficult to find baby formula in the United States.

Abbott Laboratories said Wednesday it could restart infant formula production at its troubled Michigan facility within two weeks.

In February, the company recalled some infant formulas, including certain Similac products, made at the Sturgis plant following complaints about bacterial infections in babies who had consumed the products.

The news comes a day after US retailers including Target Corp, CVS Health Corp and Walgreens Boots Alliance said they have limited purchases of infant formula due to tight supplies.

Abbott will restart production of EleCare, Alimentum and metabolic formulas first, followed by Similac and other brands, after receiving the go-ahead from the US Food and Drug Administration (FDA).

Once production resumes, it will take six to eight weeks before the product returns to shelves.

Abbott is the leading supplier of infant formula in the US and the recall has caused shortages across the country, forcing many leading retailers to limit purchases.

The FDA has said it is working with manufacturers to alleviate supply problems and that several companies are at or above capacity.

The limits come after Abbott Laboratories, the main supplier, in February recalled some infant formulas, including Similac, made at its plant in Michigan due to complaints of bacterial infections in babies consuming the products.

The FDA said it is taking several steps, including working with Abbott and other manufacturers to ease supply problems.

The agency said several infant formula manufacturers are meeting or exceeding capacity levels to meet current demand and that more infant formula was purchased in the month of April than in the month prior to the recall.

“We are doing everything in our power to ensure that a suitable product is available where and when they need it,” FDA Commissioner Robert Califf said in a statement.

About 40 percent of baby formula products sold out in the United States last month, said Ben Reich, chief executive of the data firm Datasembly.

Supply chain issues, product recalls and historical inflation have exacerbated shortages, he added.

Source link

Related Articles

Leave a Comment

The Float